New tools to track FSHD in wheelchair users
NCT ID NCT05453461
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find better ways to measure disease progression in people with advanced facioscapulohumeral muscular dystrophy (FSHD) who use wheelchairs. Researchers will test various muscle strength and function tests over two years in 30 adults. The goal is to develop reliable tools for future treatment trials in this group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
Nice, Alpes Maritimes, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the hidden progression of muscular dystrophy?
- Personalized exercise program aims to boost mobility in rare muscle diseases
- New tools aim to speed up FSHD drug trials
- New tool could better track facial muscle health in rare muscle disease
- New drug aims to build muscle in rare muscular dystrophy
- FSHD patients unite: new registry aims to accelerate research and care